Literature DB >> 20040168

Time trends in preventive drug treatment after myocardial infarction in older patients.

Wouter de Ruijter1, Margot W M de Waal, Jacobijn Gussekloo, Willem J J Assendelft, Jeanet W Blom.   

Abstract

Secondary preventive drug treatment in patients aged > or =60 years with a history of myocardial infarction was investigated for age-dependent differences in time trends. Sixteen general practices in the Netherlands participated. Preventive treatment with at least three of four drugs (antithrombotics, statins, beta-blockers, and/or angiotensin-converting enzyme inhibitors) increased significantly over time in all three age strata of older patients. Although the greatest relative increase (2.2 times greater) took place in patients aged > or =80 years, these patients consistently had most room for improvement.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20040168      PMCID： PMC2801784          DOI： 10.3399/bjgp10X482103

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


  6 in total

1.  Two decades of progress in preventing vascular disease.

Authors:  Salim Yusuf
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

2.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.

Authors:  Sidney C Smith; Jerilyn Allen; Steven N Blair; Robert O Bonow; Lawrence M Brass; Gregg C Fonarow; Scott M Grundy; Loren Hiratzka; Daniel Jones; Harlan M Krumholz; Lori Mosca; Richard C Pasternak; Thomas Pearson; Marc A Pfeffer; Kathryn A Taubert
Journal:  Circulation       Date:  2006-05-16       Impact factor: 29.690

Review 3.  Epidemiology, clinical features, and prognosis of acute myocardial infarction in the elderly.

Authors:  Michael W Rich
Journal:  Am J Geriatr Cardiol       Date:  2006 Jan-Feb

4.  Evidence for inequalities in the management of coronary heart disease in Scotland.

Authors:  C R Simpson; P C Hannaford; D Williams
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

5.  Trends in secondary prevention of ischaemic heart disease in the UK 1994 2005: use of individual and combination treatment.

Authors:  S DeWilde; I M Carey; N Richards; P H Whincup; D G Cook
Journal:  Heart       Date:  2007-05-31       Impact factor: 5.994

6.  Secondary prevention of coronary heart disease in older patients after the national service framework: population based study.

Authors:  Sheena E Ramsay; Peter H Whincup; Debbie A Lawlor; Olia Papacosta; Lucy T Lennon; Mary C Thomas; Shah Ebrahim; Richard W Morris
Journal:  BMJ       Date:  2006-01-09
  6 in total
  8 in total

1.  Age- and gender-related differences in drug utilisation and adverse drug reaction patterns among patients in a coronary care unit.

Authors:  Nitin Subhashchandra Kunnoor; Padmini Devi; Deepak Yogesh Kamath; Naveen Anthony; Jesso George
Journal:  Singapore Med J       Date:  2014-04       Impact factor: 1.858

2.  GPs' perspectives on preventive care for older people: a focus group study.

Authors:  Yvonne M Drewes; Julia M Koenen; Wouter de Ruijter; D J Annemarie van Dijk-van Dijk; Gerda M van der Weele; Barend J C Middelkoop; Ria Reis; Willem J J Assendelft; Jacobijn Gussekloo
Journal:  Br J Gen Pract       Date:  2012-11       Impact factor: 5.386

3.  GPs' perspectives on secondary cardiovascular prevention in older age: a focus group study in the Netherlands.

Authors:  Petra G van Peet; Yvonne M Drewes; Jacobijn Gussekloo; Wouter de Ruijter
Journal:  Br J Gen Pract       Date:  2015-11       Impact factor: 5.386

4.  Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?

Authors:  Petra G van Peet; Jacobijn Gussekloo; Wendy P J den Elzen; Jeanet W Blom; Margot W M de Waal; Wouter de Ruijter
Journal:  Scand J Prim Health Care       Date:  2015       Impact factor: 2.581

5.  Prescribing and medical non-adherence after myocardial infarction: qualitative interviews with general practitioners in Germany.

Authors:  Christian Freier; Christoph Heintze; Wolfram J Herrmann
Journal:  BMC Fam Pract       Date:  2020-05-08       Impact factor: 2.497

6.  Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.

Authors:  Nele Laleman; Séverine Henrard; Marjan van den Akker; Geert Goderis; Frank Buntinx; Gijs Van Pottelbergh; Bert Vaes
Journal:  BMC Cardiovasc Disord       Date:  2018-11-06       Impact factor: 2.298

7.  Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional study.

Authors:  J P Sheppard; S Singh; K Fletcher; R J McManus; J Mant
Journal:  BMJ       Date:  2012-07-12

8.  NT-proBNP best predictor of cardiovascular events and cardiovascular mortality in secondary prevention in very old age: the Leiden 85-plus Study.

Authors:  Petra G van Peet; Yvonne M Drewes; Anton J M de Craen; Jacobijn Gussekloo; Wouter de Ruijter
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.